We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Red Blood Cell Transfusion Benefits Analyzed for Trauma Patients

By LabMedica International staff writers
Posted on 02 Jul 2014
The risks and benefits of red blood cell transfusions for patients with trauma and major bleeding might vary considerably based on a patient's predicted risk of death on arrival at a trauma center.

Trauma patients who have the highest predicted risk of death on arrival at a trauma center receive the greatest benefit from red blood cell transfusions, but for those with the lowest predicted risk of death at baseline red blood cell transfusion is associated with a higher chance of death.

Scientists at the London School of Hygiene and Tropical Medicine (UK) evaluated the association between receiving red blood cell (RBC) transfusion versus not receiving a RBC transfusion with deaths by all causes at 28 days post-trauma. More...
The findings were stratified by predicted risk of death based on clinical observations on arrival at the trauma center. The investigators included 20,127 trauma patients with significant bleeding from 274 hospitals in 40 countries in their study.

The authors found that those at greatest predicted risk of dying, greater than 50%, had a smaller chance of death from all causes if they were transfused, while for those in the 21% to 50% risk group there was no significant difference in their chance of dying based on whether they are transfused or not. Patients at a 6% to 10% chance of death had a high odd ratio (OR) of 2.31 for dying if they received a transfusion, while for those whose initial risk was below 6%, the OR for death associated with transfusion was very high at 5.40. RBC transfusion was associated with 5.1 more deaths per 100 patients in the patient group with the lowest predicted risk of death but with 11.9 fewer deaths per 100 patients in the group with the highest predicted risk of death.

The authors concluded that although RBC transfusion might be life-saving for patients with hemorrhagic shock, uncertainty remains about the best early transfusion strategy in other patients. Their study suggests that blood transfusion could be harmful for those patients whose predicted risk of death is low. However, as the study was observational, important biases cannot be ruled out, and they do not claim a causal link.

Druin Burch, MD, a consulting editor of the journal, said, “With so many dying each year, and with deaths from injury set to rise in importance as road traffic crashes and violent injuries account for a greater portion of the global burden of disease, we have a compelling reason to improve and rationalize our transfusion strategies.” The study was published on June 17, 2014, in the journal Public Library of Science Medicine.

Related Links:

London School of Hygiene and Tropical Medicine



New
Gold Member
Cardiovascular Risk Test
Metabolic Syndrome Array I & II
Portable Electronic Pipette
Mini 96
New
Automatic Chemiluminescence Immunoassay Analyzer
Shine i2000
New
Autoimmune Liver Diseases Assay
Microblot-Array Liver Profile Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: AiPlex VAS for the MosaiQ platform is designed to help reduce time-to-diagnosis for patients with autoimmune vasculitis (Photo courtesy of AliveDx)

Novel Multiplex Assay Supports Diagnosis of Autoimmune Vasculitis

Autoimmune vasculitis and related conditions are difficult to diagnose quickly and accurately, often requiring multiple tests to confirm the presence of specific autoantibodies. Traditional methods can... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Technology

view channel
Image: The sensor can help diagnose diabetes and prediabetes on-site in a few minutes using just a breath sample (Photo courtesy of Larry Cheng/Penn State)

Graphene-Based Sensor Uses Breath Sample to Identify Diabetes and Prediabetes in Minutes

About 37 million U.S. adults live with diabetes, and one in five is unaware of their condition. Diagnosing diabetes often requires blood draws or lab visits, which are costly and inconvenient.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.